ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 249 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,549,379 | +1.1% | 1,385,207 | +24.5% | 0.02% | +5.3% |
| Q2 2023 | $7,464,788 | -28.1% | 1,112,487 | -5.4% | 0.02% | -26.9% |
| Q1 2023 | $10,384,574 | -3.4% | 1,176,056 | -16.4% | 0.03% | -13.3% |
| Q4 2022 | $10,750,901 | +7.7% | 1,407,186 | +0.4% | 0.03% | +3.4% |
| Q3 2022 | $9,978,000 | -11.7% | 1,401,339 | +0.3% | 0.03% | -6.5% |
| Q2 2022 | $11,306,000 | +46.5% | 1,397,533 | +151.3% | 0.03% | +82.4% |
| Q1 2022 | $7,720,000 | +356.5% | 556,199 | +1224.3% | 0.02% | +466.7% |
| Q1 2021 | $1,691,000 | -52.4% | 42,000 | -30.1% | 0.00% | -57.1% |
| Q4 2020 | $3,553,000 | +74.0% | 60,088 | +43.1% | 0.01% | +40.0% |
| Q3 2020 | $2,042,000 | +0.5% | 42,000 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $2,032,000 | +29.9% | 42,000 | -25.4% | 0.01% | 0.0% |
| Q1 2020 | $1,564,000 | +10.7% | 56,296 | +19.2% | 0.01% | +66.7% |
| Q4 2019 | $1,413,000 | +8.9% | 47,235 | +12.5% | 0.00% | 0.0% |
| Q3 2019 | $1,298,000 | -64.2% | 42,000 | -44.0% | 0.00% | -66.7% |
| Q2 2019 | $3,623,000 | – | 75,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |